Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles (2015)
- Authors:
- USP affiliated authors: FERREIRA, ELIZABETH IGNE - FCF ; CONSIGLIERI, VLADI OLGA - FCF ; CHACRA, NÁDIA ARACI BOU - FCF
- Unidade: FCF
- DOI: 10.1590/s1984-82502015000300008
- Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA; NANOPARTÍCULAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 51, n. 3, p. 561-567, 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MONTEIRO, Lis Marrie et al. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 3, p. 561-567, 2015Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502015000300008. Acesso em: 19 abr. 2024. -
APA
Monteiro, L. M., Tavares, G. D., Ferreira, E. I., Consiglieri, V. O., Bou-Chacra, N. A., & Löbenberg, R. (2015). Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles. Brazilian Journal of Pharmaceutical Sciences, 51( 3), 561-567. doi:10.1590/s1984-82502015000300008 -
NLM
Monteiro LM, Tavares GD, Ferreira EI, Consiglieri VO, Bou-Chacra NA, Löbenberg R. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 3): 561-567.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1590/s1984-82502015000300008 -
Vancouver
Monteiro LM, Tavares GD, Ferreira EI, Consiglieri VO, Bou-Chacra NA, Löbenberg R. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 3): 561-567.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1590/s1984-82502015000300008 - FCF desenvolve medicamento utilizando nanotecnologia
- Development and characterization of zidovudine and poly n-butylcyanoacrylate nanoparticles coated with hyaluronic acid
- Synthesis and characterization of n-trimethylchitosan coated poly (n-butylcyanoacrylate) nanoparticles
- Synthesis and characterization of N-trimethylchitosan coated poly(N-butylcyanoacrylate) nanoparticles
- Development of zidovudine and poly n-butylcyanoacrylate nanoparticles coated with hyaluronic acid
- Desenvolvimento de nanocápsulas contendo nimodipino para formulação de produto inovador
- Development of zidovudine and poly n-butyl cyanoacrylate nanoparticles coated with hyaluronic acid for incorporation into transdermal gel
- Development and method validation to evaluate the entrapment efficiency of polymeric nanoparticles containing new antileishmanicidal drug: Hydroxymethylnitrofural (NFOH)
- Derivative spectrophotometric method for determination of Acyclovir in polymeric nanoparticles
- N,N,N,-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nonoparticles: a potential oral drug delivery system
Informações sobre o DOI: 10.1590/s1984-82502015000300008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
